Insulin glargine 300 U/ml comparable to insulin degludec in first time in range endpoint study
Insulin glargine 300U/ml for people with type 1 diabetes has met primary endpoint in the InRange head-to-head study versus insulin degludec, according to findings presented today at the Advanced ...